visceral adipose tissue comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-07-26. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Because growth hormone is released in pulses, single measurements can misrepresent overall secretion. Investigators sometimes use repeated sampling or overnight profiles to capture the pattern rather than a single value. Provocative testing, in which a stimulus is given and the response is tracked over time, offers another way to characterize the axis. Each approach carries trade-offs between sensitivity, burden on the participant, and the influence of non-target variables.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Ten years earlier, in 2005, the Minnesota Department of Health notified the federal Centers for Disease Control and Prevention (CDC) that four cases of Salmonella typhimurium (S. typhimurium) with an indistinguishable pulsed-field gel electrophoresis (PFGE) subtype (CDC PulseNet pattern JPXX01.1173) had been identified. The only common exposure among the four ill individuals was that all had eaten at one of two Cold Stone Creamery stores. All cases had eaten cake batter flavor ice cream in the week before the onset of symptoms. After a thorough investigation, 25 cases were identified in nine states (Minnesota, Oregon, Washington, Virginia, Ohio, California, Illinois, Massachusetts, Michigan, and Pennsylvania); 24 reported eating cake batter ice cream from Cold Stone Creamery.
=== Water location === Dr. Alain Gachet founded Radar Technologies International (RTI) in 1999 to use satellite generated data to identify probable locations of precious metals and during its use found it could also detect water. The system developed with this data, WATEX, uses about 80 percent of its data inputs from publicly available NASA information. This free information allowed RTI to develop the WATEX system to successfully locate water sources, such as in 2004 at refugee camps during the War in Darfur.
=== United States === In the United States, Brandon Teena (1972–1993) is a well-known victim of corrective rape (and thereafter murder) for being a trans man. The book All She Wanted (1996) and the two films The Brandon Teena Story (1998) and Boys Don't Cry (1999) were about him.
=== Weighted boots === Weighted boots of several styles may be used if the diver will be working heavy. Some are in the form of clogs which strap on over the boots, and others use lead inner soles. Ankle weights are also an option, but less comfortable. These weights give the diver better stability when working upright on the bottom, which can significantly improve productivity for some kinds of work.
Sources: en.wikipedia.org
May 23 May 2026 White House shooting: A gunman opens fire at a security booth outside the White House complex in Washington, D.C., before being fatally shot by the Secret Service. A bystander is also injured and is in critical condition. Hasan Piker and Medea Benjamin are subpoenaed by US officials over their Cuban trip. May 24 – At least 19 people are injured in Atlantic Beach, South Carolina, during a stampede at an annual motorcycle rally. May 25 Iran war: Trump honors the 13 servicemembers who were killed during the Operation Epic Fury phase of the Iran war at Arlington National Cemetery on Memorial Day. The US Central Command reports "self-defense" strikes on Iran, saying that the ceasefire is still in place, with several Iranian soldiers reportedly killed. According to Iranian sources, prior to the US attacks, the Iranian military targeted a ship at sea. 2026 NBA playoffs: In basketball, the New York Knicks eliminate the Cleveland Cavaliers in four games with a 130–93 victory at Rocket Arena in Cleveland, Ohio, to win the NBA Eastern Conference and advance to the 2026 NBA Finals, their first appearance in the NBA Finals since 1999. They will face the winner of the Western Conference finals between the Oklahoma City Thunder and San Antonio Spurs. May 26 2028 United States presidential election: American television writer Dan Greaney announces that he will run for the Republican nomination to succeed incumbent U.S. president Donald Trump in 2028.
Chet Faliszek (; born 1965) is an American video game writer who has worked for companies like Valve and Bossa Studios, having been involved in the story writing for series such as Half-Life, Portal, and Left 4 Dead.
Urocortin III, a 38–41 amino acid peptide, is a member of the CRF (corticotropin-releasing factor), also known as CRH (corticotropin-releasing hormone) family of peptides, with a long evolutionary lineage. Separate chromosomes harbouring two exons each are home to the genes encoding UCN, UCN2, and UCN3. A gene on human chromosome 10p15 at location 5.40 Mb encodes the urocortin, UCN III, which has been discovered more recently. A 161 amino acid precursor is produced when the UCN III gene is translated. Mature UCN III with 38 or 41 amino acids would be produced by proteolytic cleavage between arginine- or threonine-lysine residues. Human plasma contains both the 38 and 41 amino acid forms of UCN III, although the 38 amino acid form is more prevalent, according to findings from high-performance liquid chromatography. Each urocortin peptide has a distinct expression location and function, yet they all share conserved structural similarity. Urocortins' structures, as determined by nuclear magnetic resonance, exhibit alpha-helical secondary structures, which support biological activity and binding selectivity.
Italian forces entered British Somaliland from Abyssinia on 4 August 1940, overcame the garrison at Hargeisa, and advanced north-east towards the capital Berbera. The British force, including a platoon of 43 Rhodesians in the 2nd Battalion of the Black Watch, took up positions on six hills overlooking the only road towards Berbera and engaged the Italians at the Battle of Tug Argan. Amid heavy fighting, the Italians gradually made gains and by 14 August had almost pocketed the Commonwealth forces. The British retreated to Berbera between 15 and 17 August, the Rhodesians making up the left flank of the rearguard, and by 18 August had evacuated by sea. The Italians took the city and completed their conquest of British Somaliland a day later. No. 237 Squadron embarked on reconnaissance flights and supported ground assaults on Italian desert outposts during July and August 1940. Two British brigades from West Africa arrived to reinforce Kenya's northern frontier in early July—the partly Rhodesian-officered Nigeria Regiment joined the front at Malindi and Garissa, while a battalion of the Gold Coast Regiment, also with Rhodesian commanders attached, relieved the KAR at Wajir. The British forces in East Africa adopted the doctrine of "mobile defence" that was already being used in the Western Desert in North Africa—units embarked on long, constant patrols to guard wells and deny water supplies to the Italians. The British evacuated their north forward position at Buna in September 1940, and expected an attack on Wajir soon after, but the Italians never attempted an assault.
== Uterine leiomyomas vs. uterine leiomyosarcomas == Leiomyomas are benign smooth muscle tumors that have overlapping features with leiomyosarcomas. Although both originate from smooth muscle, leiomyomas do not, in contrast, mature into leiomyosarcomas. Leiomyomas are seen in premenopausal women and are symptomatic 20–50% of the time, while leiomyosarcomas, the most common uterine sarcomas, are seen in older postmenopausal women, with 40-60 being the peak age incidence. Since leiomyomas are benign and mostly asymptomatic, minimally invasive treatment modalities are used to treat them. For this same reason, distinguishing them from LMSs before surgical procedures is crucial to ensure that laparoscopic procedures or diagnosis delay will not lead to heightened morbidity given the poor prognosis of LMS. For example, the FDA has warned against using morcellation for benign leiomyomas, as those with unsuspected sarcomas are at risk of cancer spread.
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
It acts upstream at the pituitary receptor and depends on functioning somatotroph cells to produce any effect. Growth hormone injections bypass that step and deliver the hormone directly. The pharmacokinetic profiles and the resulting feedback on the body's own secretion therefore differ.